This milestone is a testament to King’s College Hospital Dubai’s unwavering dedication to offering groundbreaking, patient-centered care.

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

As one of the leading facilities for advanced neurological and Parkinson’s care in the region, King’s College Hospital Dubai ...

SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson's disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...

New hope as surprising Parkinson’s treatment deemed safe in clinical trials - More than 150,000 people in the UK are living ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...

Stem cell therapies for Parkinson’s deemed safe in clinical trials - The studies also ‘offer hope’ that transplanted cells ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time vs placebo.